Renal anaemia - CKD 5D

Autor: K. Takasawa, C. Takaeda, M. Higuchi, T. Maeda, N. Tomosugi, N. Ueda, Y. Sasaki, M. Ikezoe, M. Hagiwara, S. Furuhata, M. Murakami, Y. Shimonaka, S. Yamazaki, S. Hamahata, M. Oue, T. Kuragano, M. Furuta, M. Yahiro, A. Kida, Y. Otaki, Y. Hasuike, H. Nonoguchi, T. Nakanishi, P. Sarafidis, A. Rumjon, D. Ackland, H. Maclaughlin, S. S. Bansal, I. C. Macdougall, V. Panichi, A. Rosati, E. Malagnino, R. Giusti, A. Casani, G. Betti, P. Conti, G. Bernabini, C. Gabrielli, D. Caiani, A. Scatena, M. Migliori, F. Pizzarelli, E. Mitsopoulos, M. Tsiatsiou, I. Minasidis, V. Kousoula, E. Intzevidou, P. Passadakis, V. Vargemezis, D. Tsakiris, S. W. Lines, A. M. Carter, E. J. Dunn, M. J. Wright, R. Aoyagi, T. Miura, L. De Paola, G. Lombardi, G. Coppolino, L. Lombardi, H. Fukumoto, S. Kaibe, M. Tokuyama, M. Hiwasa, T. Miyamoto, H. Ohue, A. Matsumoto, K. Toyoda, J. Rottembourg, C. Emery, A. Lafuma, J. Wernli, L. Zakin, L. Mahi, D. Borzych-Duzalka, Y. Bilginer, L. Pape, I. S. Ha, M. Bak, A. Chua, L. Rees, S. Pesle, F. Cano, A. Urzykowska, S. Emre, J. Russcasso, V. Ramela, N. Printza, C. White, D. Kuzmanovska, V. Andrea, D. Muller-Wiefel, B. Warady, F. Schaefer, J. H. Chung, M. K. Park, H. L. Kim, B. C. Shin, T. Fujikawa, T. Kuji, M. Kakimoto, K. Shibata, H. Satta, M. Nishihara, S. Kawata, N. Koguchi, Y. Toya, S. Umemura, V. David, G. Michel, H. Maxime, L. Paul, K. Sebastien, V. Francois, V. Kuntsevich, Y. Dou, S. Thijssen, N. W. Levin, P. Kotanko, B. S. Kim, W. D. Park, H. C. Song, H. G. Kim, Y.-O. Kim, K. Woodburn, K.-L. Fong, Y. Moriya, Y. Tagawa, F. Kanda, N. Morita, G. London, P. Zaoui, A. Covic, F. Dellanna, D. Goldsmith, L. Gesualdo, J. Mann, C. Combe, M. Turner, M. Meunzberg, K. Macdonald, I. Abraham, A. Guerin, M. Diaconita, R. Apruzzese, A. Kruse, G. Ouellet, C. Bond, D. Jensen, S. Wang, E. Pham, J. Rubin, M. Sika, R. Niecestro, S. Sloneker, P. Strzemienski, E. Solon, D. Stamopoulos, N. Mpakirtzi, E. Grapsa, B. Gogola, E. Manios, N. Afentakis, J. Ewer

Publikováno v: Nephrology Dialysis Transplantation. 27:ii483-ii491

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5bf03a6630db96bf531ec4474740526a
https://doi.org/10.1093/ndt/gfs244

Efficacy of rabeprazole once daily for acid-related disorders

Autor: F, Lanza, K D, Bardhan, C, Perdomo, R, Niecestro, J, Barth

Publikováno v: Digestive diseases and sciences. 46(3)

Proton-pump inhibitors (PPIs) have revolutionized the treatment of gastroesophageal reflux disease (GERD) and peptic ulcer. To evaluate the efficacy of the new PPI rabeprazole, 12 controlled clinical trials were conducted worldwide-three for each ind

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d936ce9929810fe0721c1d34df0c7229
https://pubmed.ncbi.nlm.nih.gov/11318537

Phase II study of single agent perifosine in patients with hepatocellular carcinoma (HCC)

Autor: Peter Sportelli, John Nemunaitis, R. Niecestro, L. T. Campos, D. Richards, Minal A. Barve, L. Gardner, Joe Stephenson

Publikováno v: Journal of Clinical Oncology. 27:e15505-e15505

e15505 Background: Perifosine (Peri) is a novel oral alkylphospholipid with effects on multiple signal transduction pathways including Akt, MAPK and JNK. Unresectable HCC continues to have dismal prognosis. In a phase III randomized study, sorafenib

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8e6502fef3a87408119ad24ccee0c057
https://doi.org/10.1200/jco.2009.27.15_suppl.e15505

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.